Moreover, blocking GPR75 with AAA replicated the effects of 20-HETE inhibition, significantly suppressing Ang II-induced ROS generation and Ca2+/CaN/NFAT3 pathway activation, ultimately reversing Ang II-induced cardiac hypertrophy. Here, NFATC4 is linked to cardiac hypertrophy.